RT Journal Article
SR Electronic
T1 Unnecessary antibiotic treatment of children hospitalized with RSV-bronchiolitis: risk factors and prescription patterns
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.17.21260687
DO 10.1101/2021.07.17.21260687
A1 Obolski, Uri
A1 Kassem, Eias
A1 Na’amnih, Wasef
A1 Tannous, Shebly
A1 Kagan, Viktoria
A1 Muhsen, Khitam
YR 2021
UL http://medrxiv.org/content/early/2021/07/20/2021.07.17.21260687.abstract
AB Background Respiratory syncytial virus (RSV) is a main cause of respiratory tract infections, especially affecting young children. Antibiotics are often unnecessarily prescribed for the treatment of RSV. Such treatments can have effects on antibiotic resistance in future bacterial infections of treated patients and the general population.Objectives We sought to understand the risk factors for and patterns of unnecessary antibiotic prescription in children with RSV.Methods In a single center retrospective study in Israel, we obtained data of children aged <2 years (n=1015) hospitalized for RSV-bronchiolitis during 2008-2018, and ascertained not to have bacterial coinfections. Antibiotic misuse was defined as prescription of antibiotics during hospitalization of the study population. Patient and clinical variables were assessed as predictors of unnecessary antibiotic treatment in a multivariable logistic regression model.Results Unnecessary antibiotic treatment rate of children infected with RSV and ascertained not to have a bacterial coinfection was estimated at 33.4% (95% CI 30.5%-36.4%). Increased likelihood of antibiotic misuse was associated with drawing bacterial cultures, and with variables indicative of a severe patient status: lower oxygen saturation, higher body temperature, tachypnea and prior recent emergency room visit. Older age and female sex were also associated with increased likelihood of unnecessary antibiotic treatment.Conclusions Unnecessary antibiotic treatment in RSV patients was highly common and may be largely attributed to the physicians’ perception of patients’ severity. Improving prescription guidelines, implementing antibiotic stewardship programs and utilizing decision support systems may help achieve a better balance between prescribing and withholding antibiotic treatment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding as receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:he study was approved by the Institutional Review Board (Helsinki) Committee of Hillel Yaffe Medical Center. Since this was a retrospective study, using archived medical records, an exemption from informed consent was granted by the Helsinki Committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGiven IRB and legal restrictions, we cannot provide any access to individual-level data, which we obtained from archived medical records from a single medical center and were collected as part of patients' clinical care, and not for research purposes. Legal and ethical restrictions apply for secondary usage of these data in research. Readers may contact Uri Obolski (the corresponding author) for further information.